Hisamitsu Pharmaceutical Co., Inc. (HTSUF) Stock Analysis
DELISTED
What happened to Hisamitsu Pharmaceutical Co., Inc. (HTSUF) stock?
Hisamitsu Pharmaceutical Co., Inc. (HTSUF) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
P/E 17.01 means the share price is 17.01 times one year of earnings per share. Market cap $2.04B is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Hisamitsu Pharmaceutical Co., Inc. (HTSUF). Hisamitsu Pharmaceutical Co., Inc. is a Japanese manufacturer and seller of pharmaceuticals, quasi-drugs, and medical devices, specializing in external pain relief products. The company's products are available in Japan, the United States, and Asia.
Last analyzed: Mar 16, 2026Hisamitsu Pharmaceutical Co., Inc. (HTSUF) Healthcare & Pipeline Overview
HTSUF OTC Market Information
HTSUF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy HTSUF shares?
No. HTSUF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for HTSUF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before HTSUF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Hisamitsu Pharmaceutical Co., Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.